InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Vendola, Keith. Director active across 1 company, notably NervGen Pharma Corp.. Cumulatively, 2 disclosures have been logged. History available since 27 April 2026. The latest transaction was filed on 27 April 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
2 of 2 declarations